Medicine
Clindamycin 1% gel
Clindamycin 1% gel is a generic prescription medicine for topical use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at controlled room temperature 20° to 25°C (68°…
Key facts
- Active ingredient (INN)
- Clindamycin
- Brand
- Sold under the generic name
- Strength
- 1%
- Dosage form
- Gel
- Route
- Topical
- Packs
- 1 tube and 31 more
- Manufacturers
- Alembic PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaGlenmark PharmaceuticalsIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaBryant Ranch PrepackA-S Medication SolutionsE. FougeraEncube Ethicals
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at controlled room temperature 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF01 Clindamycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 January 1987
- Identifiers
- RxCUI 2676585, 197519, 309333DailyMed set ID 6f72b852-e741-48e5-b8e1-f8a1afcfb4d4, 41ab7061-7c3a-4a4c-9c44-16851c97ad00, c205b9e8-3f62-4176-be4e-bc4b5dbf3893 +17NDC 45802-900, 46708-623, 50090-6072 +17Application ANDA212104, ANDA212466, ANDA214251 +7
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 30 g in 1 tube | 46708-623-30 | Alembic PharmaceuticalsIndia | 4 April 2024 |
| 1 tube in 1 carton / 60 g in 1 tube | 46708-623-60 | Alembic PharmaceuticalsIndia | 4 April 2024 |
| 1 tube in 1 carton / 30 g in 1 tube | 62332-623-30 | Alembic PharmaceuticalsIndia | 4 April 2024 |
| 1 tube in 1 carton / 60 g in 1 tube | 62332-623-60 | Alembic PharmaceuticalsIndia | 4 April 2024 |
| 1 tube in 1 carton / 30 g in 1 tube | 59651-806-30 | Aurobindo PharmaIndia | 18 March 2026 |
| 1 tube in 1 carton / 60 g in 1 tube | 59651-806-60 | Aurobindo PharmaIndia | 18 March 2026 |
| 1 tube in 1 carton / 30 g in 1 tube | 68462-866-35 | Glenmark PharmaceuticalsIndia | 10 February 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 68462-866-65 | Glenmark PharmaceuticalsIndia | 10 February 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 51672-1399-2 | Sun Pharmaceutical IndustriesIndia | 10 November 2020 |
| 1 tube in 1 carton / 60 g in 1 tube | 51672-1399-3 | Sun Pharmaceutical IndustriesIndia | 10 November 2020 |
| 1 tube in 1 carton / 75 g in 1 tube | 51672-1399-7 | Sun Pharmaceutical IndustriesIndia | 30 October 2024 |
| 1 tube in 1 carton / 30 g in 1 tube | 72578-118-01 | Viona PharmaceuticalsIndia | 20 September 2023 |
| 1 tube in 1 carton / 60 g in 1 tube | 72578-118-02 | Viona PharmaceuticalsIndia | 20 September 2023 |
| 1 tube in 1 carton / 30 g in 1 tube | 70771-1855-2 | Zydus LifesciencesIndia | 20 September 2023 |
| 1 tube in 1 carton / 60 g in 1 tube | 70771-1855-3 | Zydus LifesciencesIndia | 20 September 2023 |
| 1 tube in 1 carton / 30 g in 1 tube | 0168-0202-30 | E. Fougera | 28 January 2000 |
| 1 tube in 1 carton / 60 g in 1 tube | 0168-0202-60 | E. Fougera | 28 January 2000 |
| 1 tube in 1 carton / 30 g in 1 tube | 21922-027-05 | Encube Ethicals | 15 March 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 21922-027-07 | Encube Ethicals | 15 March 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 59762-3743-1 | Mylan Pharmaceuticals | 7 January 1987 |
| 1 tube in 1 carton / 60 g in 1 tube | 59762-3743-2 | Mylan Pharmaceuticals | 7 January 1987 |
| 1 tube in 1 carton / 30 g in 1 tube | 45802-900-94 | Padagis Israel Pharmaceuticals | 20 January 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 45802-900-96 | Padagis Israel Pharmaceuticals | 20 January 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 73473-300-30 | Solaris Pharma | 3 January 2025 |
| 1 tube in 1 carton / 60 g in 1 tube | 73473-300-60 | Solaris Pharma | 3 January 2025 |
| 1 tube in 1 carton / 30 g in 1 tube | 63629-8630-1 | Bryant Ranch Prepack | 20 January 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 63629-8631-1 | Bryant Ranch Prepack | 20 January 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 63629-9309-1 | Bryant Ranch Prepack | 6 July 2022 |
| 1 tube in 1 carton / 60 g in 1 tube | 72162-1436-6 | Bryant Ranch Prepack | 13 March 2024 |
| 1 tube in 1 carton / 30 g in 1 tube | 50090-5958-0 | A-S Medication Solutions | 7 April 2022 |
| 1 tube in 1 carton / 30 g in 1 tube | 50090-6072-0 | A-S Medication Solutions | 13 September 2022 |
| 1 tube in 1 carton / 30 g in 1 tube | 16714-161-01 | Northstar RX | 10 March 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 16714-161-02 | Northstar RX | 10 March 2021 |
| 1 tube in 1 carton / 60 g in 1 tube | 68788-8423-6 | Preferred Pharmaceuticals | 13 April 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 February 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Clindamycin
Clinical summary
Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cleocin Hydrochloride prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Clindamycin 1% gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.